PDPN+ CAFs facilitate the motility of OSCC cells by inhibiting ferroptosis via transferring exosomal lncRNA FTX
Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN + C...
Saved in:
Published in | Cell death & disease Vol. 14; no. 11; pp. 759 - 13 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
22.11.2023
Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN
+
CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN
+
CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN
+
CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN
+
CAFs may serve as a novel potential therapeutic target for OSCC. |
---|---|
AbstractList | Abstract Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC. Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN + CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN + CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN + CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN + CAFs may serve as a novel potential therapeutic target for OSCC. Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC.Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC. Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN+ CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN+ CAFs may serve as a novel potential therapeutic target for OSCC. Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex. FTX enhanced promoter demethylation of FEN1 by recruiting ten-eleven translocation-2 (TET2). In addition, FTX/FEN1 axis promoted OSCC cells motility by inhibiting ferroptosis. In xenograft experiments, RSL-3, a ferroptosis-inducing agent, suppressed the tumorigenesis potential of FEN1-overexpressed OSCC cells. Furthermore, Acyl-CoA synthetase long-chain family member 4 (ACSL4) was confirmed to participate in the motility promotion induced by FEN1 overexpression. FEN1 could bind to promoter region of ACSL4 and then inhibit ferroptosis in OSCC cells. Our study reveals that PDPN CAFs promote the invasiveness of OSCC cells by inhibiting ferroptosis through FTX/FEN1/ACSL4 signaling cascade. PDPN CAFs may serve as a novel potential therapeutic target for OSCC. |
ArticleNumber | 759 |
Author | Zhang, Si-en Xu, Xiaoqing Cheng, Bin Li, Weiyu Xia, Juan Ma, Zeyi Shen, Peiqi Li, Yaoyin |
Author_xml | – sequence: 1 givenname: Yaoyin surname: Li fullname: Li, Yaoyin organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology – sequence: 2 givenname: Zeyi surname: Ma fullname: Ma, Zeyi organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology – sequence: 3 givenname: Weiyu orcidid: 0000-0002-8964-6232 surname: Li fullname: Li, Weiyu organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology – sequence: 4 givenname: Xiaoqing surname: Xu fullname: Xu, Xiaoqing organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology – sequence: 5 givenname: Peiqi surname: Shen fullname: Shen, Peiqi organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology – sequence: 6 givenname: Si-en surname: Zhang fullname: Zhang, Si-en organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology – sequence: 7 givenname: Bin orcidid: 0000-0001-7288-806X surname: Cheng fullname: Cheng, Bin email: chengbin@mail.sysu.edu.cn organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology – sequence: 8 givenname: Juan orcidid: 0000-0002-4966-7119 surname: Xia fullname: Xia, Juan email: xiajuan@mail.sysu.edu.cn organization: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37993428$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kVtrFDEYhoNUbK39A15IwBuhjOY4k7lcRlcLpS1awbuQyaHNMjvZJlnp_nszO7VKL5qbnJ7340ue1-BgDKMF4C1GHzGi4lNimOG2QoRWqCYCVfQFOCKI4YoJ0R78tz4EJymtUBmUIsLrV-CQNm1LGRFHIFx9vro4hd1imaBT2g8-q2xhvrVwHfK03cHg4OWProPaDkOC_Q768db3PvvxBjobY9jkkHyCv72COaoxTYfTpb0PKazVAIdRf79YwOX1rzfgpVNDsicP8zH4ufxy3X2rzi-_nnWL80ozwXPlsEUc9UogUwtqMdasbzSiqHfGtLWhHHPDygUn2jUOOdTWvNGN0YQo0SN6DM7muiaoldxEv1ZxJ4Pycn8Q4o1UMXs9WNkTSgXHzhFDmbNtTwgTRCMsnOF1w0utD3OtTQx3W5uyXPs0fYYabdgmSURLWlbXLSno-yfoKmzjWF66pxgWlDaFevdAbfu1NY_t_dVSADIDOoaUonWPCEZy0i9n_bLol3v9kpaQeBLSk0wfxiLFD89H6RxNm0mcjf_afib1BwrPwTE |
CitedBy_id | crossref_primary_10_1007_s12672_025_02151_9 crossref_primary_10_1515_oncologie_2024_0369 crossref_primary_10_1016_j_intimp_2024_113666 crossref_primary_10_3389_fimmu_2024_1469918 crossref_primary_10_2147_IJN_S508767 crossref_primary_10_3389_fimmu_2025_1568567 crossref_primary_10_1002_mco2_70116 crossref_primary_10_3389_fimmu_2024_1485174 crossref_primary_10_25259_Cytojournal_241_2024 |
Cites_doi | 10.1038/onc.2017.184 10.1158/0008-5472.CAN-17-0994 10.1038/s41467-018-07582-3 10.1186/s13046-018-0941-x 10.1158/0008-5472.CAN-19-0819 10.21037/atm-21-2755 10.1038/s41418-019-0304-y 10.1158/1078-0432.CCR-17-2967 10.1016/j.biopha.2022.113446 10.1038/s43018-020-0082-y 10.1016/j.lfs.2020.118305 10.1016/j.cell.2018.01.009 10.1016/j.cell.2012.03.042 10.1016/j.neo.2021.05.004 10.1016/j.omtn.2020.05.033 10.1016/j.ajpath.2017.09.011 10.1261/rna.070177.118 10.1186/s12943-015-0426-x 10.3389/fimmu.2021.783362 10.1016/j.ebiom.2018.09.006 10.4149/neo_2020_200707N705 10.3389/fonc.2021.605884 10.1016/j.bbrc.2014.08.110 10.3349/ymj.2022.63.3.229 10.7150/thno.25541 10.1016/j.ebiom.2019.05.055 10.1016/j.biopha.2019.109623 10.1101/gad.276568.115 10.1016/j.cell.2017.09.021 10.1002/ijc.23611 10.1038/s41586-020-2623-z 10.1016/j.yexcr.2018.04.029 10.1186/1476-4598-12-168 10.7150/thno.19712 10.3389/froh.2021.686337 10.1016/j.ecoenv.2021.112376 10.1016/j.molonc.2014.04.009 10.1158/0008-5472.CAN-10-3228 10.1038/s41418-018-0242-0 10.1002/ijc.29464 10.1016/S0167-4889(00)00029-X 10.1038/s41419-020-02827-w 10.18632/oncotarget.3371 10.1186/s13046-021-02208-x 10.1042/BSR20130054 10.3390/cancers14235896 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 2023. The Author(s). The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 DOA |
DOI | 10.1038/s41419-023-06280-3 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection (ProQuest) ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature Link OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-4889 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_b233851ff2d34fe9b22482c018fd5675 37993428 10_1038_s41419_023_06280_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Natural Science Foundation of China grants (81602382, 81972545) – fundername: Natural Science Foundation of China grants (82170960) |
GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO E3Z EBLON EBS EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RNT RPM SNYQT TR2 UKHRP W2D AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PKEHL PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO |
ID | FETCH-LOGICAL-c485t-f1e050ba80d683e11c4b7c030bfdd96d3515d43e152cf7f0f09657c7dc22a8b03 |
IEDL.DBID | M48 |
ISSN | 2041-4889 |
IngestDate | Wed Aug 27 01:23:55 EDT 2025 Wed Jul 30 10:53:12 EDT 2025 Wed Aug 13 08:09:39 EDT 2025 Mon Jul 21 05:39:51 EDT 2025 Tue Jul 01 03:50:11 EDT 2025 Thu Apr 24 22:55:22 EDT 2025 Fri Feb 21 02:36:59 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | 2023. The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-f1e050ba80d683e11c4b7c030bfdd96d3515d43e152cf7f0f09657c7dc22a8b03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4966-7119 0000-0002-8964-6232 0000-0001-7288-806X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41419-023-06280-3 |
PMID | 37993428 |
PQID | 2892418337 |
PQPubID | 2041963 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b233851ff2d34fe9b22482c018fd5675 proquest_miscellaneous_2892946692 proquest_journals_2892418337 pubmed_primary_37993428 crossref_primary_10_1038_s41419_023_06280_3 crossref_citationtrail_10_1038_s41419_023_06280_3 springer_journals_10_1038_s41419_023_06280_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-11-22 |
PublicationDateYYYYMMDD | 2023-11-22 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cell death & disease |
PublicationTitleAbbrev | Cell Death Dis |
PublicationTitleAlternate | Cell Death Dis |
PublicationYear | 2023 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
References | Lu, Xu, Lu (CR43) 2020; 260 Stockwell, Friedmann Angeli, Bayir, Bush, Conrad, Dixon (CR11) 2017; 171 Chen, Fu, Du, Zhao, Yang, Xu (CR21) 2020; 80 Conigliaro, Costa, Lo Dico, Saieva, Buccheri, Dieli (CR31) 2015; 14 Lu, Chan, Tan, Zhang, Guo, Xu (CR46) 2022; 41 Kawase, Ishii, Nagai, Ito, Nagano, Murata (CR15) 2008; 123 Bartoschek, Oskolkov, Bocci, Lovrot, Larsson, Sommarin (CR27) 2018; 9 Hoshino, Ishii, Ito, Aoyagi, Ohtaki, Nagai (CR17) 2011; 71 Neri, Ishii, Hashimoto, Kuwata, Nagai, Date (CR16) 2015; 137 CR38 Bienkowska, Hanley, Thomas (CR2) 2021; 2 Ruivo, Adem, Silva, Melo (CR3) 2017; 77 Li, Huang, Wen, Cui, Guo, He (CR24) 2019; 44 Amini Chermahini, Rashnonejad, Harper (CR18) 2019; 25 Sun, Hao, Zhuang, Lv, Liu, Su (CR30) 2022; 63 Yang, Qu, Li, Ma, Yu (CR23) 2022; 153 Takahashi, Ishii, Neri, Yoshida, Hashimoto, Suzuki (CR28) 2015; 6 Li, Dong, Cui, Wang, Hong (CR39) 2018; 37 Rasmussen, Helin (CR40) 2016; 30 Ding, Jia, Wang, Xu, Gao, Lu (CR9) 2019; 26 Ai, Wei, Wu, Tang, Li, Zou (CR22) 2021; 11 Li, Zhou, Gao (CR20) 2018; 369 Peng, Koirala, Mo (CR32) 2017; 36 Ren, Ding, Zhang, Shi, Xu, Shen (CR7) 2018; 8 Ubellacker, Tasdogan, Ramesh, Shen, Mitchell, Martin-Sandoval (CR25) 2020; 585 Bian, Zhang, Li, Feng, Wang, Zhang (CR34) 2018; 24 Wu, Pi, Chen, Zuo, Zhou, Ouyang (CR12) 2022; 2022 Friedman, Levi-Galibov, David, Bornstein, Giladi, Dadiani (CR26) 2020; 1 Fan, Zhou, Luo, Luo, Chen, Zhao (CR8) 2021; 23 Abdel-Fatah, Russell, Albarakati, Maloney, Dorjsuren, Rueda (CR36) 2014; 8 Zhang, Keymeulen, Nelson, Tong, Yuan, Yun (CR37) 2018; 188 Kim, Lee, Lee, Shin, Lee (CR35) 2000; 1496 Pan, Du, Liu, Cheng, Zhu, Jia (CR33) 2021; 9 Yang, Yang, Zhao, Chen, Xu, Fu (CR4) 2017; 7 Jia, Li, Pan, Tao, Wang, Lu (CR41) 2020; 22 CR45 Wang, Mao, Ouyang, Liu, Lai, Liu (CR13) 2019; 26 Niu, Yang, Liu, Fang (CR10) 2020; 121 Dixon, Lemberg, Lamprecht, Skouta, Zaitsev, Gleason (CR42) 2012; 149 Wu, Lu, Li, Ma, Long, Wu (CR44) 2021; 12 Li, Tao, Gao, Li, Zheng, Zhang (CR5) 2018; 36 Ma, Liang, Zhou, Wang (CR47) 2021; 68 Su, Chen, Yao, Liu, Yu, Lao (CR1) 2018; 172 Shindo, Aishima, Ohuchida, Fujiwara, Fujino, Mizuuchi (CR29) 2013; 12 Li, Zhou, Gao (CR19) 2014; 452 Dai, Jin, Han, Huang, Ji, Xu (CR6) 2020; 11 Zhang, Guo, Wang, Li, Hou, Li (CR14) 2021; 220 J Ren (6280_CR7) 2018; 8 CW Chen (6280_CR21) 2020; 80 CF Ruivo (6280_CR3) 2017; 77 Y Wu (6280_CR12) 2022; 2022 YY Li (6280_CR5) 2018; 36 X Ding (6280_CR9) 2019; 26 K Shindo (6280_CR29) 2013; 12 YY Li (6280_CR19) 2014; 452 Y Lu (6280_CR46) 2022; 41 KJ Bienkowska (6280_CR2) 2021; 2 JM Ubellacker (6280_CR25) 2020; 585 M Bartoschek (6280_CR27) 2018; 9 X Niu (6280_CR10) 2020; 121 G Amini Chermahini (6280_CR18) 2019; 25 YY Li (6280_CR20) 2018; 369 6280_CR45 Y Zhang (6280_CR14) 2021; 220 JT Fan (6280_CR8) 2021; 23 Y Ai (6280_CR22) 2021; 11 J Lu (6280_CR43) 2020; 260 Z Wu (6280_CR44) 2021; 12 A Takahashi (6280_CR28) 2015; 6 WW Yang (6280_CR4) 2017; 7 J Yang (6280_CR23) 2022; 153 A Hoshino (6280_CR17) 2011; 71 SJ Dixon (6280_CR42) 2012; 149 LL Ma (6280_CR47) 2021; 68 W Li (6280_CR24) 2019; 44 A Kawase (6280_CR15) 2008; 123 S Neri (6280_CR16) 2015; 137 IS Kim (6280_CR35) 2000; 1496 BR Stockwell (6280_CR11) 2017; 171 A Conigliaro (6280_CR31) 2015; 14 K Zhang (6280_CR37) 2018; 188 W Dai (6280_CR6) 2020; 11 Y Sun (6280_CR30) 2022; 63 S Su (6280_CR1) 2018; 172 WX Peng (6280_CR32) 2017; 36 M Jia (6280_CR41) 2020; 22 Z Bian (6280_CR34) 2018; 24 6280_CR38 Q Li (6280_CR39) 2018; 37 KD Rasmussen (6280_CR40) 2016; 30 M Wang (6280_CR13) 2019; 26 L Pan (6280_CR33) 2021; 9 G Friedman (6280_CR26) 2020; 1 TM Abdel-Fatah (6280_CR36) 2014; 8 |
References_xml | – ident: CR45 – volume: 36 start-page: 5661 year: 2017 end-page: 7 ident: CR32 article-title: LncRNA-mediated regulation of cell signaling in cancer publication-title: Oncogene doi: 10.1038/onc.2017.184 – volume: 77 start-page: 6480 year: 2017 end-page: 8 ident: CR3 article-title: The biology of cancer exosomes: insights and new perspectives publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-0994 – volume: 9 year: 2018 ident: CR27 article-title: Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing publication-title: Nat Commun doi: 10.1038/s41467-018-07582-3 – volume: 37 start-page: 265 year: 2018 ident: CR39 article-title: Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-018-0941-x – volume: 80 start-page: 2273 year: 2020 end-page: 85 ident: CR21 article-title: Long noncoding RNA MRPL23-AS1 promotes adenoid cystic carcinoma lung metastasis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-19-0819 – volume: 9 start-page: 1369 year: 2021 ident: CR33 article-title: LncRNA FTX promotes the malignant progression of colorectal cancer by regulating the miR-214-5p-JAG1 axis publication-title: Ann Transl Med doi: 10.21037/atm-21-2755 – volume: 26 start-page: 2329 year: 2019 end-page: 43 ident: CR13 article-title: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA publication-title: Cell Death Differ doi: 10.1038/s41418-019-0304-y – volume: 24 start-page: 4808 year: 2018 end-page: 19 ident: CR34 article-title: LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-2967 – volume: 153 start-page: 113446 year: 2022 ident: CR23 article-title: Biological role of long non-coding RNA FTX in cancer progression publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2022.113446 – volume: 1 start-page: 692 year: 2020 end-page: 708 ident: CR26 article-title: Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4(+) and PDPN(+) CAFs to clinical outcome publication-title: Nat Cancer doi: 10.1038/s43018-020-0082-y – volume: 260 start-page: 118305 year: 2020 ident: CR43 article-title: LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53 publication-title: Life Sci doi: 10.1016/j.lfs.2020.118305 – volume: 172 start-page: 841 year: 2018 end-page: 56 ident: CR1 article-title: CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness publication-title: Cell doi: 10.1016/j.cell.2018.01.009 – volume: 149 start-page: 1060 year: 2012 end-page: 72 ident: CR42 article-title: Ferroptosis: an iron-dependent form of nonapoptotic cell death publication-title: Cell doi: 10.1016/j.cell.2012.03.042 – volume: 23 start-page: 692 year: 2021 end-page: 703 ident: CR8 article-title: Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway publication-title: Neoplasia doi: 10.1016/j.neo.2021.05.004 – volume: 22 start-page: 319 year: 2020 end-page: 28 ident: CR41 article-title: LINC-PINT suppresses the aggressiveness of thyroid cancer by downregulating miR-767-5p to induce TET2 expression publication-title: Mol Ther Nucleic Acids doi: 10.1016/j.omtn.2020.05.033 – volume: 188 start-page: 242 year: 2018 end-page: 51 ident: CR37 article-title: Overexpression of flap endonuclease 1 correlates with enhanced proliferation and poor prognosis of non-small-cell lung cancer publication-title: Am J Pathol doi: 10.1016/j.ajpath.2017.09.011 – volume: 25 start-page: 1211 year: 2019 end-page: 7 ident: CR18 article-title: RNAscope in situ hybridization-based method for detecting DUX4 RNA expression in vitro publication-title: RNA doi: 10.1261/rna.070177.118 – volume: 14 year: 2015 ident: CR31 article-title: CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA publication-title: Mol Cancer doi: 10.1186/s12943-015-0426-x – volume: 12 start-page: 783362 year: 2021 ident: CR44 article-title: Identification and validation of ferroptosis-related LncRNA signatures as a novel prognostic model for colon cancer publication-title: Front Immunol doi: 10.3389/fimmu.2021.783362 – volume: 36 start-page: 209 year: 2018 end-page: 20 ident: CR5 article-title: Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p publication-title: EBioMedicine doi: 10.1016/j.ebiom.2018.09.006 – volume: 68 start-page: 165 year: 2021 end-page: 73 ident: CR47 article-title: Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4 publication-title: Neoplasma doi: 10.4149/neo_2020_200707N705 – volume: 11 start-page: 605884 year: 2021 ident: CR22 article-title: Exosomal LncRNA LBX1-AS1 derived From RBPJ overexpressed-macrophages inhibits oral squamous cell carcinoma progress via miR-182-5p/FOXO3 publication-title: Front Oncol doi: 10.3389/fonc.2021.605884 – volume: 452 start-page: 490 year: 2014 end-page: 6 ident: CR19 article-title: Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2014.08.110 – volume: 63 start-page: 229 year: 2022 end-page: 40 ident: CR30 article-title: MEG3 LncRNA from exosomes released from cancer-associated fibroblasts enhances cisplatin chemoresistance in SCLC via a MiR-15a-5p/CCNE1 axis publication-title: Yonsei Med J doi: 10.3349/ymj.2022.63.3.229 – volume: 8 start-page: 3932 year: 2018 end-page: 48 ident: CR7 article-title: Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19 publication-title: Theranostics doi: 10.7150/thno.25541 – ident: CR38 – volume: 44 start-page: 298 year: 2019 end-page: 310 ident: CR24 article-title: LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.05.055 – volume: 121 start-page: 109623 year: 2020 ident: CR10 article-title: LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2019.109623 – volume: 30 start-page: 733 year: 2016 end-page: 50 ident: CR40 article-title: Role of TET enzymes in DNA methylation, development, and cancer publication-title: Genes Dev doi: 10.1101/gad.276568.115 – volume: 171 start-page: 273 year: 2017 end-page: 85 ident: CR11 article-title: Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease publication-title: Cell doi: 10.1016/j.cell.2017.09.021 – volume: 123 start-page: 1053 year: 2008 end-page: 9 ident: CR15 article-title: Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma publication-title: Int J Cancer doi: 10.1002/ijc.23611 – volume: 585 start-page: 113 year: 2020 end-page: 8 ident: CR25 article-title: Lymph protects metastasizing melanoma cells from ferroptosis publication-title: Nature doi: 10.1038/s41586-020-2623-z – volume: 369 start-page: 43 year: 2018 end-page: 53 ident: CR20 article-title: Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-beta1 mediated by podoplanin publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2018.04.029 – volume: 12 year: 2013 ident: CR29 article-title: Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas publication-title: Mol Cancer doi: 10.1186/1476-4598-12-168 – volume: 7 start-page: 3700 year: 2017 end-page: 14 ident: CR4 article-title: Epiregulin promotes lung metastasis of salivary adenoid cystic carcinoma publication-title: Theranostics doi: 10.7150/thno.19712 – volume: 2 start-page: 686337 year: 2021 ident: CR2 article-title: Cancer-associated fibroblasts in oral cancer: a current perspective on function and potential for therapeutic targeting publication-title: Front Oral Health doi: 10.3389/froh.2021.686337 – volume: 220 start-page: 112376 year: 2021 ident: CR14 article-title: LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling publication-title: Ecotoxicol Environ Saf doi: 10.1016/j.ecoenv.2021.112376 – volume: 8 start-page: 1326 year: 2014 end-page: 38 ident: CR36 article-title: Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer publication-title: Mol Oncol doi: 10.1016/j.molonc.2014.04.009 – volume: 71 start-page: 4769 year: 2011 end-page: 79 ident: CR17 article-title: Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-3228 – volume: 26 start-page: 1750 year: 2019 end-page: 65 ident: CR9 article-title: A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer publication-title: Cell Death Differ doi: 10.1038/s41418-018-0242-0 – volume: 137 start-page: 784 year: 2015 end-page: 96 ident: CR16 article-title: Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma publication-title: Int J Cancer doi: 10.1002/ijc.29464 – volume: 1496 start-page: 333 year: 2000 end-page: 40 ident: CR35 article-title: Gene expression of flap endonuclease-1 during cell proliferation and differentiation publication-title: Biochim Biophys Acta doi: 10.1016/S0167-4889(00)00029-X – volume: 11 year: 2020 ident: CR6 article-title: Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt/beta-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma publication-title: Cell Death Dis doi: 10.1038/s41419-020-02827-w – volume: 2022 start-page: 6177553 year: 2022 ident: CR12 article-title: Ginsenoside Rh4 inhibits colorectal cancer cell proliferation by inducing ferroptosis via autophagy activation publication-title: Evid Based Complement Altern Med – volume: 6 start-page: 9531 year: 2015 end-page: 41 ident: CR28 article-title: Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth publication-title: Oncotarget doi: 10.18632/oncotarget.3371 – volume: 41 start-page: 3 year: 2022 ident: CR46 article-title: Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-021-02208-x – volume: 14 year: 2015 ident: 6280_CR31 publication-title: Mol Cancer doi: 10.1186/s12943-015-0426-x – volume: 41 start-page: 3 year: 2022 ident: 6280_CR46 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-021-02208-x – volume: 7 start-page: 3700 year: 2017 ident: 6280_CR4 publication-title: Theranostics doi: 10.7150/thno.19712 – volume: 26 start-page: 2329 year: 2019 ident: 6280_CR13 publication-title: Cell Death Differ doi: 10.1038/s41418-019-0304-y – volume: 452 start-page: 490 year: 2014 ident: 6280_CR19 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2014.08.110 – volume: 8 start-page: 3932 year: 2018 ident: 6280_CR7 publication-title: Theranostics doi: 10.7150/thno.25541 – volume: 22 start-page: 319 year: 2020 ident: 6280_CR41 publication-title: Mol Ther Nucleic Acids doi: 10.1016/j.omtn.2020.05.033 – volume: 36 start-page: 209 year: 2018 ident: 6280_CR5 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2018.09.006 – volume: 71 start-page: 4769 year: 2011 ident: 6280_CR17 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-3228 – volume: 2022 start-page: 6177553 year: 2022 ident: 6280_CR12 publication-title: Evid Based Complement Altern Med – volume: 8 start-page: 1326 year: 2014 ident: 6280_CR36 publication-title: Mol Oncol doi: 10.1016/j.molonc.2014.04.009 – volume: 188 start-page: 242 year: 2018 ident: 6280_CR37 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2017.09.011 – volume: 369 start-page: 43 year: 2018 ident: 6280_CR20 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2018.04.029 – volume: 585 start-page: 113 year: 2020 ident: 6280_CR25 publication-title: Nature doi: 10.1038/s41586-020-2623-z – volume: 153 start-page: 113446 year: 2022 ident: 6280_CR23 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2022.113446 – volume: 11 start-page: 605884 year: 2021 ident: 6280_CR22 publication-title: Front Oncol doi: 10.3389/fonc.2021.605884 – volume: 12 start-page: 783362 year: 2021 ident: 6280_CR44 publication-title: Front Immunol doi: 10.3389/fimmu.2021.783362 – volume: 26 start-page: 1750 year: 2019 ident: 6280_CR9 publication-title: Cell Death Differ doi: 10.1038/s41418-018-0242-0 – volume: 25 start-page: 1211 year: 2019 ident: 6280_CR18 publication-title: RNA doi: 10.1261/rna.070177.118 – volume: 37 start-page: 265 year: 2018 ident: 6280_CR39 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-018-0941-x – volume: 80 start-page: 2273 year: 2020 ident: 6280_CR21 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-19-0819 – volume: 23 start-page: 692 year: 2021 ident: 6280_CR8 publication-title: Neoplasia doi: 10.1016/j.neo.2021.05.004 – volume: 44 start-page: 298 year: 2019 ident: 6280_CR24 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.05.055 – volume: 63 start-page: 229 year: 2022 ident: 6280_CR30 publication-title: Yonsei Med J doi: 10.3349/ymj.2022.63.3.229 – volume: 6 start-page: 9531 year: 2015 ident: 6280_CR28 publication-title: Oncotarget doi: 10.18632/oncotarget.3371 – volume: 172 start-page: 841 year: 2018 ident: 6280_CR1 publication-title: Cell doi: 10.1016/j.cell.2018.01.009 – ident: 6280_CR38 doi: 10.1042/BSR20130054 – volume: 149 start-page: 1060 year: 2012 ident: 6280_CR42 publication-title: Cell doi: 10.1016/j.cell.2012.03.042 – volume: 9 year: 2018 ident: 6280_CR27 publication-title: Nat Commun doi: 10.1038/s41467-018-07582-3 – volume: 24 start-page: 4808 year: 2018 ident: 6280_CR34 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-2967 – volume: 137 start-page: 784 year: 2015 ident: 6280_CR16 publication-title: Int J Cancer doi: 10.1002/ijc.29464 – volume: 220 start-page: 112376 year: 2021 ident: 6280_CR14 publication-title: Ecotoxicol Environ Saf doi: 10.1016/j.ecoenv.2021.112376 – volume: 1496 start-page: 333 year: 2000 ident: 6280_CR35 publication-title: Biochim Biophys Acta doi: 10.1016/S0167-4889(00)00029-X – volume: 9 start-page: 1369 year: 2021 ident: 6280_CR33 publication-title: Ann Transl Med doi: 10.21037/atm-21-2755 – volume: 1 start-page: 692 year: 2020 ident: 6280_CR26 publication-title: Nat Cancer doi: 10.1038/s43018-020-0082-y – ident: 6280_CR45 doi: 10.3390/cancers14235896 – volume: 11 year: 2020 ident: 6280_CR6 publication-title: Cell Death Dis doi: 10.1038/s41419-020-02827-w – volume: 77 start-page: 6480 year: 2017 ident: 6280_CR3 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-0994 – volume: 121 start-page: 109623 year: 2020 ident: 6280_CR10 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2019.109623 – volume: 36 start-page: 5661 year: 2017 ident: 6280_CR32 publication-title: Oncogene doi: 10.1038/onc.2017.184 – volume: 68 start-page: 165 year: 2021 ident: 6280_CR47 publication-title: Neoplasma doi: 10.4149/neo_2020_200707N705 – volume: 171 start-page: 273 year: 2017 ident: 6280_CR11 publication-title: Cell doi: 10.1016/j.cell.2017.09.021 – volume: 12 year: 2013 ident: 6280_CR29 publication-title: Mol Cancer doi: 10.1186/1476-4598-12-168 – volume: 2 start-page: 686337 year: 2021 ident: 6280_CR2 publication-title: Front Oral Health doi: 10.3389/froh.2021.686337 – volume: 123 start-page: 1053 year: 2008 ident: 6280_CR15 publication-title: Int J Cancer doi: 10.1002/ijc.23611 – volume: 30 start-page: 733 year: 2016 ident: 6280_CR40 publication-title: Genes Dev doi: 10.1101/gad.276568.115 – volume: 260 start-page: 118305 year: 2020 ident: 6280_CR43 publication-title: Life Sci doi: 10.1016/j.lfs.2020.118305 |
SSID | ssj0000330256 |
Score | 2.4588668 |
Snippet | Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer... Abstract Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results... |
SourceID | doaj proquest pubmed crossref springer |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 759 |
SubjectTerms | 13/44 14 14/19 38 38/109 42 45/61 45/91 631/67/1536/1665 631/67/327 82 Antibodies Biochemistry Biomedical and Life Sciences Cancer Cancer-Associated Fibroblasts - metabolism Carcinoma, Squamous Cell - pathology Cell Biology Cell Culture Cell survival Demethylation Endonuclease FEN1 protein Ferroptosis Ferroptosis - genetics Fibroblasts Fibroblasts - metabolism Head and Neck Neoplasms - metabolism Humans Immunology Invasiveness Life Sciences Membrane Glycoproteins - metabolism Motility Mouth Neoplasms - pathology Non-coding RNA Oral cancer Oral carcinoma Oral squamous cell carcinoma RNA, Long Noncoding - genetics RNA, Long Noncoding - metabolism Squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck - pathology Therapeutic targets Tumor Microenvironment Tumorigenesis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuCMor0FZG4laixq_EOS5LVxUSSwWttDfLTxGpJNUmrdp_z9jJLkW8Llxj52HPjOebePwNQm9kIbz0OmaJe5Nz72VuakdzHak3SVlSn0qyfFyWJ-f8w0qs7pT6ijlhIz3wOHFHhkIQJUgI1DEefG3A50hqCyKDE4B24-oLPu9OMJXWYAjTwZlPp2QKJo96Tng8r0NjMQMqYfH5yRMlwv7focxfdkiT41k8Qg8nxIhn45c-Rvd8u4vujzUkb5-g7vT96fIQz2eLHgdtR9JtjwHX4ZhnF1E27gL-9GU-x_EvfY_NLW7ar41pYsYzDn697i6Hrm96fN1oPCQkG_kaodHfdH33Dd5-0drPyxlenK2eovPF8dn8JJ-qKOSWSzHkgfhCFEbLwpWSeUIsN5UF2zbBubp0DBCN49AgqA1VKELkg6ls5SylWpqCPUM7bdf6Fwh7UcuKmlLo2nItq9rUOpTGFtS5YEqeIbKZUWUnivFY6eJCpa1uJtUoBQVSUEkKimXocHvP5Uiw8dfe76Kgtj0jOXa6ACqjJpVR_1KZDO1txKwmi-0VBJ4AZiRjVYZeb5vB1qJodOu7q7FP5OOvaYaej-qx_RJWAdKDWC5Dbzf68uPhfx7Qy_8xoFfoAY2KTUhO6R7aGdZXfh-w0mAOkll8BwrTCsc priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICNxK1Ed24mdE1oWVhUSSwWttDfLzxKpxMsmRfTf40myWyGg19hJnMyM_c14_A1CryUpvfQassS9ybn3Mje1o7kG6s2iqqgfSrJ8WlZHp_zjqlxNAbduSqvczonDRO2ihRj5YXIM0mIjGRNv1z9yqBoFu6tTCY2b6BZQl4FWi5XYxVhIctbTkj6dlSFMHna84HBqh0JJAyrTFPTHejTQ9v8La_61TzosP4t76O6EG_FsFPR9dMO3D9DtsZLk5UMUj98fLw_wfLbocNB2pN72OKE7DNl2gLVxDPjz1_kcQ6y-w-YSN-23xjSQ94yD32ziuo9d0-Gfjcb9gGeBtTE1-l-xi9_T289b-2U5w4uT1SN0uvhwMj_Kp1oKueWy7PNQeFISoyVxlWS-KCw3wiYLN8G5unIs4RrHU0NJbRCBBGCFEVY4S6mWhrDHaK-NrX-KsC9rKaipSl1brqWoTa1DZSyhzgVT8QwV2z-q7EQ0DvUuztWw4c2kGqWgkhTUIAXFMnSwu2c90mxc2_sdCGrXEyiyhwtxc6Ymi1OGJu-7LEKgjvHga5PAiqSWFDK4MrlJGdrfillNdtupKy3L0Ktdc7I4EI1ufbwY-wArf00z9GRUj91ImEh4L3l0GXqz1Zerh___g55dP5bn6A5UuYcjkJTuo71-c-FfJCzUm5eDwv8GKCgC9Q priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKKyQuiDeBgozErUQ4tpM4x7CwqlZiqWgr7c3yEyKVpNqkiP57xk6yCFGQuMZ2XjNjf2PPfIPQa0FyJ5wKUeJOp9w5kerK0lQF6s2sKKiLJVk-rovjc77a5Js9ROdcmBi0Hykt4zQ9R4e97XnGQ7oNDbUIqIC54xY6CFTtoNsHdb06Xe12Vgi46LCQTxkyhIkbBv-2CkWy_psQ5h-no3HRWd5Ddye0iOvx_e6jPdc-QLfH-pHXD1F38v5kfYQX9bLHXpmRcNthwHQ4xNgFhI07jz-dLhY47ND3WF_jpv3a6CZEO2Pvttvucuj6psffG4WHiGIDVyM0uh9d332Dp1-05vO6xsuzzSN0vvxwtjhOpwoKqeEiH1KfOZITrQSxhWAuywzXpQG71t7aqrAM0Izl0JBT40tPfOCCKU1pDaVKaMIeo_22a91ThF1eiZLqIleV4UqUla6UL7Qh1FqvC56gbP6j0kz04qHKxYWMx9xMyFEKEqQgoxQkS9DRbszlSK7xz97vgqB2PQMxdrzQbb_ISVGkpuBz55n31DLuXaUBoghqSCa8zcE5StDhLGY5WWsvwekEICMYKxP0atcMdhZEo1rXXY19Ahd_RRP0ZFSP3ZuwElAe-HEJejPry6-b__2Dnv1f9-foTqh1HxIhKT1E-8P2yr0ARDTol5MJ_ASKqwH8 priority: 102 providerName: Springer Nature |
Title | PDPN+ CAFs facilitate the motility of OSCC cells by inhibiting ferroptosis via transferring exosomal lncRNA FTX |
URI | https://link.springer.com/article/10.1038/s41419-023-06280-3 https://www.ncbi.nlm.nih.gov/pubmed/37993428 https://www.proquest.com/docview/2892418337 https://www.proquest.com/docview/2892946692 https://doaj.org/article/b233851ff2d34fe9b22482c018fd5675 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9NAEB71EKgviBtDiRaJt2Kw18euHxBKTaIqUkPUNlLeLO8FkVI7jVPUvPDbmfURkEh5sSXv-pwZzzf27vcBvOdepLnO7ShxLdxQa-6KRFE3t9SbfhxTXUuynI_js2k4mkWzPejkjtoHWO0s7aye1HS1-Hh3s_mCAf-5mTLOP1WhH9qpONTqFFCO75V9OMTMxKyiwXkL9-s3MxbvmOLbuTO7dz2ChwHDpB1affa_UlXN6L8Lhv7zC7XOTMPH8KiFlKTf-MAT2NPFU3jQiExunsFy8nUyJick7Q8rYnLZ0HJrgsiP2JF4FoeT0pBvl2lK7Hf8iogNmRc_5mJux0QTo1ercrkuq3lFfs5zsq6xrmV0xEZ9V1blNZ5-UciLcZ8Mr2bPYTocXKVnbquz4MqQR2vX-NqLPJFzT8U80L4vQ8EkRr8wSiWxChDzqBAbIioNM56xjDFMMiUpzbnwghdwUJSFfgVERwlnVMRRnsgw5ywRSW5iIT2qlBFx6IDfPdJMtiTkVgtjkdU_wwOeNRbJ0CJZbZEscOBku8-yoeD4b-9Ta6ltT0ufXW8oV9-zNhozQbEyj3xjqApCoxOBQIZT6fncqAhLKAeOOztnnUtmWJqiU_EgYA682zZjNFrT5IUub5s-lrE_oQ68bPxjeyWdWznwoXOYPwe__4Ze33ugN3BEref6vkvpMRysV7f6LUKktejBPpuxHhz2-6PLEa5PB-PJBW5N47RXf3bo1ZFhl78GvwHgAQ0q |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2ggJHgVKI6dh7OAaFly2pL26WCrbQ3N35BpJIsmxTYP8VvxJNXhYDeeo0dx_GMPd_Y4_kQesFJZLjJIErcSD80hvsy1dTPIPVmEMfUNJQsh7N4ehy-X0SLDfSrvwsDYZX9mtgs1LpUsEe-4xwDZ2w4Y8mb5TcfWKPgdLWn0GjVYt-sfziXrXq9t-vk-5LSybv5eOp3rAK-CnlU-zYwJCIy40THnJkgUKFMlNN1abVOY82chdehK4iosoklFvKjJCrRitKMS8Jcu1fQVWd4CTh7ySIZ9nQIYwAhurs5hPGdKgxCuCVEgUKBcrfk_WH_GpqAf2Hbv85lG3M3uYVudjgVj1rFuo02THEHXWuZK9d3UXm0ezTbxuPRpMI2U22qb4MdmsQQ3QfYHpcWf_g0HmM4G6iwXOO8-JLLHOKssTWrVbmsyyqv8Pc8w3WDnyFLpCs0P8uq_Oq-flqoj7MRnswX99DxpYzyfbRZlIV5iLCJUp5QGUdZqsKMJ6lMMxtLRajWVsahh4J-RIXqEpsDv8apaA7YGRetFISTgmikIJiHtod3lm1ajwtrvwVBDTUhJXfzoFx9Ft0MF5I6bz8KrKWahdak0oEjThUJuNWRc8s8tNWLWXTrRCXOtdpDz4diN8NBNFlhyrO2DrAApNRDD1r1GHrCEocvnQfpoVe9vpw3_v8fenRxX56h69P54YE42JvtP0Y3KKhvEPiUbqHNenVmnjgcVsunjfJjdHLZs-03VmM_0A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEG8CBYwEpxJtYufhHBDa7nbVUlhWpZX25sYvWKkkZbMF9q_x6_DksRUCeus1dhzHM7a_8YznA3jJg9hwk2OUuJF-ZAz3Zaapn2PqzTBJqKkpWT5Mkr3j6N0snm3Ar-4uDIZVdmtivVDrUuEZed8ZBm6z4YylfduGRUxH47dn33xkkEJPa0en0ajIgVn9cOZb9WZ_5GT9itLx7tFwz28ZBnwV8Xjp29AEcSBzHuiEMxOGKpKpcnovrdZZopnb7XXkCmKqbGoDi7lSUpVqRWnOZcBcu9dgM0WrqAebO7uT6eH6hCdgDAFFe1MnYLxfRWGEd4YoEipQ7hbAP3bDmjTgX0j3Ly9tvfmNb8OtFrWSQaNmd2DDFHfhesNjuboH5XQ0nWyT4WBcEZurJvG3IQ5bEoz1Q6RPSks-fhoOCXoKKiJXZF58mcs5Rl0TaxaL8mxZVvOKfJ_nZFmjacwZ6QrNz7Iqv7qvnxbqcDIg46PZfTi-knF-AL2iLMwjICbOeEplEueZinKeZjLLbSJVQLW2Mok8CLsRFapNc45sG6eidrczLhopCCcFUUtBMA-21--cNUk-Lq29g4Ja18QE3fWDcvFZtPNdSOps_zi0lmoWWZNJB5U4VUHIrY6dkebBVidm0a4albjQcQ9erIvdfEfR5IUpz5s6yAmQUQ8eNuqx7glLHdp09qQHrzt9uWj8_z_0-PK-PIcbbqaJ9_uTgydwk6L2hqFP6Rb0lotz89SBsqV81mo_gZOrnnC_AfjcRWs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PDPN+%2B+CAFs+facilitate+the+motility+of+OSCC+cells+by+inhibiting+ferroptosis+via+transferring+exosomal+lncRNA+FTX&rft.jtitle=Cell+death+%26+disease&rft.au=Li%2C+Yaoyin&rft.au=Ma%2C+Zeyi&rft.au=Li%2C+Weiyu&rft.au=Xu%2C+Xiaoqing&rft.date=2023-11-22&rft.eissn=2041-4889&rft.volume=14&rft.issue=11&rft.spage=759&rft_id=info:doi/10.1038%2Fs41419-023-06280-3&rft_id=info%3Apmid%2F37993428&rft.externalDocID=37993428 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |